You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 34 No. 5, May 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Fatty Acid Composition of Lipids in Cerebral Myelin and Synaptosomes in Phenylketonuria and Down Syndrome

Ronald C. Johnson, PhD; Charles M. McKean, MD; Shantilal N. Shah, PhD

Arch Neurol. 1977;34(5):288-294.


Abstract

• Lipid and fatty acid composition of myelin and synaptosomes isolated from brains of phenylketonuric (PKU) and Down syndrome (DS) patients and patients with neither of these disorders was determined. No differences were observed in the proportions of cholesterol to phospholipids in synaptosomes and cholesterol to galactolipids to phospholipids in myelin or in the fatty acid composition of phospholipids in synaptosomes. However, the myelin from PKU brains contained reduced proportions of unsaturated and long-chain fatty acids. We conclude that genetic PKU and its experimental model have in common a defect in cerebral fatty acid metabolism, and that cerebral lipid abnormalities in this condition, rather than being generalized, may be confined to the glial cell population that synthesizes myelin. We further conclude that DS is not associated with an abnormality of cerebral lipid metabolism.



Author Affiliations

From the Langley Porter Neuropsychiatric Institute, University of California-San Francisco, Brain-Behavior Research Center at Sonoma State Hospital, Eldridge.


Footnotes

Accepted for publication Jan 17, 1977.

Reprint requests to Brain-Behavior Research Center, Sonoma State Hospital, Eldridge, CA 95431 (Dr Shah).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antioxidant enzymes and fatty acid status in erythrocytes of Down syndrome patients
Pastor et al.
Clin. Chem. 1998;44:924-929.
ABSTRACT | FULL TEXT  

Magnetic Resonance Imaging Evaluation of Delayed Myelination in Down Syndrome: A Case Report and Review of the Literature
Koo et al.
J Child Neurol 1992;7:417-421.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.